Tectonic Therapeutic, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tectonic Therapeutic, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2017 to Q3 2024.
  • Tectonic Therapeutic, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$17.7M, a 76.2% decline year-over-year.
  • Tectonic Therapeutic, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $1.5M.
  • Tectonic Therapeutic, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $12.2M.
  • Tectonic Therapeutic, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$106M, a 11.1% increase from 2021.
  • Tectonic Therapeutic, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$119M, a 0.49% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.5M -$17.7M -$7.66M -76.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $9.17M -$12.7M -$2.22M -21.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 $11.4M -$15.2M -$776K -5.37% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 $12.2M $47.1M +$72.1M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$60M -$10.1M +$12.9M +56.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$72.9M -$10.5M +$17.6M +62.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$90.5M -$14.4M +$15.4M +51.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$106M -$25M +$3.19M +11.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$109M -$23M +$9.64M +29.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$119M -$28.1M +$3.33M +10.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$122M -$29.8M -$2.93M -10.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$119M -$28.2M -$96K -0.34% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$119M -$32.6M +$4.17M +11.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$123M -$31.4M -$2.56M -8.88% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$121M -$26.9M -$926K -3.57% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$120M -$28.1M -$5.47M -24.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$114M -$36.8M -$19.6M -115% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$94.6M -$28.8M -$12.8M -79.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$81.8M -$26M -$8.87M -51.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$73M -$22.7M -$6.64M -41.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$66.3M -$17.1M -$5.55M -47.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$60.8M -$16.1M -$5.55M -52.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$55.2M -$17.1M -$8.86M -108% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$46.4M -$16M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$11.6M -$5.15M -80% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$10.5M -$7.97M -315% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$8.24M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q3 2017 -$6.44M Jun 24, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$2.53M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.